Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

Amit Shah Urges Realtors To Include Green Spaces, Embrace RERA & Skill Development

Amit Shah Urges Realtors To Include Green Spaces, Embrace RERA & Skill Development

Odisha Bags Massive ₹67,000 Crore Investment Boost At Hyderabad Meet

Odisha Bags Massive ₹67,000 Crore Investment Boost At Hyderabad Meet

India To Slash Import Duties On Key Omani Goods Under New Trade Pact

India To Slash Import Duties On Key Omani Goods Under New Trade Pact

'My Government Stands With Every Investor Wishing To Invest In Madhya Pradesh': CM Mohan Yadav

'My Government Stands With Every Investor Wishing To Invest In Madhya Pradesh': CM Mohan Yadav

ADB Injects $4.26 Billion In India’s Skills, Renewable Energy, Urban, & Healthcare Projects

ADB Injects $4.26 Billion In India’s Skills, Renewable Energy, Urban, & Healthcare Projects